Patents Assigned to CYTOCHROMA DEVELOPMENT INC.
  • Patent number: 9066917
    Abstract: There is provided a method of producing a mixed metal compound comprising at least Mg2+ and at least Fe3+ having an aluminum content of less than 10000 ppm, having an average crystal size of less than 20 nm (200 A) comprising the steps of: (a) combining a Mg2+ salt and a Fe3+ salt with Na2CO3 and NaOH to produce a slurry, wherein the pH of the slurry is maintained at from 9 5 to 1 1, and wherein the Na2CO3 is provided at an excess of 0 to 4.0 moles than is required to complete the reaction (b) subjecting the slurry to mixing under conditions providing a power per unit volume of 0 03 to 1.6 kW/m3 (c) separating the mixed metal compound from the slurry, to obtain a crude product having a dry solid content of at least 10 wt % (d) drying the crude product either by (i) heating the crude product to a temperature of no greater than 150° C. and sufficient to provide a water evaporation rate of 0.
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: June 30, 2015
    Assignee: CYTOCHROMA DEVELOPMENT INC.
    Inventors: Richard Jonathan Applewhite, James David Morrison, Maurice Sydney Newton, Nigel Peter Rhodes, Christopher John Rickard
  • Publication number: 20140205667
    Abstract: There is provided a method of producing a mixed metal compound comprising at least Mg2+ and at least Fe3 + having an aluminium content of less than 10000 ppm, having an average crystal size of less than 20 nm (200 A) comprising the steps of: (a) combining a Mg2+ salt and a Fe3 + salt with Na2CO3 and NaOH to produce a slurry, wherein the pH of the slurry is maintained at from 9 5 to 1 1, and wherein the Na2CO3 is provided at an excess of 0 to 4.0 moles than is required to complete the reaction (b) subjecting the slurry to mixing under conditions providing a power per unit volume of 0 03 to 1.6 kW/m3 (c) separating the mixed metal compound from the slurry, to obtain a crude product having a dry solid content of at least 10 wt % (d) drying the crude product either by (i) heating the crude product to a temperature of no greater than 150° C. and sufficient to provide a water evaporation rate of 0.
    Type: Application
    Filed: March 24, 2014
    Publication date: July 24, 2014
    Applicant: CYTOCHROMA DEVELOPMENT INC.
    Inventors: Richard Jonathan Applewhite, James David Morrison, Maurice Sydney Newton, Nigel Peter Rhodes, Christopher John Rickard
  • Publication number: 20140120180
    Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.
    Type: Application
    Filed: October 28, 2013
    Publication date: May 1, 2014
    Applicant: CYTOCHROMA DEVELOPMENT INC.
    Inventors: Norman Bryson Roberts, Maurice Webb Chester, Benjamin Joseph
  • Publication number: 20130323325
    Abstract: The present invention provides a composition comprising (i) a mixed metal compound containing at least one trivalent metal selected from iron (lll) and aluminium and at least one divalent metal selected from of magnesium, iron, zinc, calcium, lanthanum and cerium, (ii) xanthan gum (iii) at least one of (a) polyvinyl pyrrolidone (b) locust bean gum (c) methyl cellulose wherein the composition has been irradiated with ionising radiation in an amount of at least 4 kGy.
    Type: Application
    Filed: February 3, 2011
    Publication date: December 5, 2013
    Applicant: CYTOCHROMA DEVELOPMENT INC.
    Inventors: Richard Jonathan Applewhite, Maurice Sydney Newton, Alexis John Toft
  • Patent number: 8568792
    Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: October 29, 2013
    Assignee: Cytochroma Development Inc.
    Inventors: Norman B Roberts, Maurice Webb, Benjamin J Rankin
  • Publication number: 20120201864
    Abstract: There is provided a method of producing a mixed metal compound comprising at least Mg2+ and at least Fe+ having an aluminium content of less than 10000 ppm, having an average crystal size of less than 20 nm (200 A) comprising the steps of: (a) combining a Mg2+ salt and a Fe3+ salt with Na2CO3 and NaOH to produce a slurry, wherein the pH of the slurry is maintained at from 9 5 to 1 1, and wherein the Na2CO3 is provided at an excess of 0 to 4.0 moles than is required to complete the reaction (b) subjecting the slurry to mixing under conditions providing a power per unit volume of 0 03 to 1.6 kW/m3 (c) separating the mixed metal compound from the slurry, to obtain a crude product having a dry solid content of at least 10 wt % (d) drying the crude product either by (i) heating the crude product to a temperature of no greater than 150° C. and sufficient to provide a water evaporation rate of 0.
    Type: Application
    Filed: August 2, 2010
    Publication date: August 9, 2012
    Applicant: CYTOCHROMA DEVELOPMENT INC.
    Inventors: Richard J. Applewhite, James D. Morrison, Maurice S. Newton, Nigel P. Rhodes, Christopher J. Rickard